RE: loss of confidence8 May 2022 14:16
Oleric,
Excellent posts - balanced and objective. Reaction from the rampers yesterday was not surprising as they cannot/will not tolerate any comments, no matter how accurate, that contain anything that might be deemed negative.
The launch of AxisBiotix was a damp squib and, so far, there has been nothing by way of factual evidence, for example meaningful sales data, to change that position. I am reasonably confident that we will receive more positive news later in the year but as for it being some sort of universal panacea for psoriasis and any other skin ailment you care to think about as suggested by the ramping crew then....NO!
If AxisBiotix was as beneficial as has been frequently suggested then it would have been plastered over the UK media....nada. Not even a token squeak in the Daily Mail that I'm aware of!!
AxisBiotix was last year's big story and, conveniently, we now have the Croda initiative to take our attention. I would urge all/any investor to check-out Croda's investors presentation 29th March 'Accelerating growth in Consumer Care'. Some time talking about Sederma's continued research and investment into matrixyl. It's significant . Yet no mention of the SBTX lysate which has been bigged up as the next great skin care treatment, certainly by the ramping crew, and supposedly due for launch later this year. A missed opportunity or what??